Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2024 Publisher: Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip, HA46QD, United Kingdom
Metronidazole 500 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White to off white, oblong shaped, coated tablets, debossed with ‘M’ and '500’on one face and a break line on the other face. The size is 16.6 mm x 7.3 mm. |
Each film-coated tablet contains 500 mg metronidazole.
Excipient(s) with known effect:
Each tablet contains 1.981mg of sodium.
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methronidazole |
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
| List of Excipients |
|---|
|
Tablet core: Cellulose microcrystalline Tablet coat: Hypromellose 2910 (5cps) |
Metronidazole film-coated tablets are available in clear PVC/Aluminium foil containing 21 film-coated tablets.
Not all pack sizes may be marketed.
Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip, HA46QD, United Kingdom
PL 16363/0574
22/11/2019
| Drug | Countries | |
|---|---|---|
| METRONIDAZOLE | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.